about
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technologyPlacenta growth factor in sickle cell disease: association with hemolysis and inflammation.Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell diseasePathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapyNaloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemiaA multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.Chemical-induced atrial thrombosis in NTP rodent studies.Granulocytic adhesive interactions and their role in sickle cell vaso-occlusion.Haptoglobin gene polymorphisms and interleukin-6 and -8 levels in patients with sickle cell anemia.Hospital admission for acute painful episode following methacholine challenge in an adolescent with sickle cell disease.Asthma management in sickle cell diseaseLeukotriene pathway in sickle cell disease: a potential target for directed therapy.Impact of Mannose-Binding Protein Gene Polymorphisms in Omani Sickle Cell Disease Patients.Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.Structure-function relations of human hemoglobins.Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.Experimental malaria: the in vitro and in vivo blood pressure paradox.Tumor necrosis factor-superfamily 15 gene expression in patients with sickle cell disease.Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.Influence of serum 25-hydroxyvitamin D on the rate of pain episodes in Nigerian children with sickle cell anaemia.Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients
P2860
Q33398661-6776A84B-203C-4A04-A0B2-B91BE7209E09Q33722654-F814C22E-B209-4394-9793-F939A5E14054Q33886125-9F563C27-F87A-4539-8109-7014F1256A66Q34431518-6819977C-7781-4BD5-8C3D-B2616A0A75D5Q35567943-E75C05CA-1726-4AE9-859D-700F583E9443Q35749650-EA1DFB07-4A01-4E48-9832-45DD7F3C643AQ36115743-ED6B30FF-9433-4274-BDB4-4E381DB4447FQ36210042-A99837E5-67B4-4B36-879C-739E56A15594Q36307582-813B3370-42B6-4130-97CA-E845C05CA44EQ36387512-5EEC7C0F-1648-4A55-B0A9-F653FF295F3EQ37059569-06371BC3-1DE6-4271-808B-DDE8819797ECQ37346672-9217553A-174F-470D-9E44-08298ED269A7Q37810108-CE178350-F2A8-4DD0-8AC9-CB3C97DB4138Q38677935-BE2B1364-A64B-452B-B387-C213FEE6C0A5Q39166162-A0ECE0A7-083A-47F1-AD95-36D79B23A3A1Q40248915-C433DC7F-4BF2-4505-9BBA-5AD23AAF1BC2Q41878174-C1274CA7-E708-4FC9-9314-59FB1DE6A506Q42086258-793F91B0-8CEB-4328-B563-A95C86BFFA40Q43095831-91CF3A1B-5F38-4181-A814-445A17E01059Q50230368-F4DA1CD3-FBC6-45C2-AF20-970E53C78521Q50248736-0101889F-5C25-4380-8CE6-5260455FC28AQ56529775-5B3907B4-5EE3-4AC6-A4FD-73D116F0FD07
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cytokines in sickle cell disease.
@ast
Cytokines in sickle cell disease.
@en
type
label
Cytokines in sickle cell disease.
@ast
Cytokines in sickle cell disease.
@en
prefLabel
Cytokines in sickle cell disease.
@ast
Cytokines in sickle cell disease.
@en
P2093
P2860
P1433
P1476
Cytokines in sickle cell disease.
@en
P2093
Anil Pathare
David Dennison
Salam Al Kindi
Shahina Daar
P2860
P304
P356
10.1080/10245330310001604719
P577
2003-10-01T00:00:00Z